Brian is the Head of External Innovation for the Rare Diseases Therapeutic Area at Sanofi. In this role, he and his teams are responsible for working with senior leadership to define an overall portfolio strategy and execute on the external activities, with accountability for identification and securing of external innovation solutions from around the globe that meet the needs of the R&D portfolio. Prior to this role, Brian was a member of the Sanofi Sunrise team, where his responsibilities spanned a range of activities related to building and maintaining a vibrant portfolio of investments, including Warp Drive Bio and Thermalin.
Prior to joining Sanofi in 2014, Brian served as an advisor to a wide array of life science organizations, along with venture capital groups, where he contributed to multiple teams reaching key R&D and financing milestones.
From 2009-2013, Brian was the Vice President of R&D at Satori Pharmaceuticals. Before Satori, Brian worked at Pfizer, rising to the level of Senior Director. Brian and his teams have been involved in the discovery of more than 20 development candidates, including Draxxin™, Convenia™, Cerina™ and Slentrol™
Brian earned his bachelor’s degree from Colgate University in 1989. Following a year as a Fulbright Fellow in Dortmund, Germany, he initiated his doctoral work at the Massachusetts Institute of Technology, receiving his doctorate in chemistry in 1994.